Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06364800
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-15
First Post:
2024-04-10
Brief Title:
Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal Antibody
Sponsor:
Beijing 302 Hospital
Organization:
Beijing 302 Hospital
Organization Data
Organization:
Beijing 302 Hospital
Class:
OTHER
Study ID:
GDT-001-07-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Beijing 302 Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Beijing GD Initiative Cell Therapy Technology Co Ltd | INDUSTRY |
| Chinese Academy of Medical Sciences | OTHER |